Calidi

$Calidi(CLDI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-028030  Size: 6 KB 网页链接

$Calidi(CLDI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-25-022372  Act: 34  Size: 12 MB 网页链接

$Calidi(CLDI)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0002109116-26-000002  Act: 34  Size: 6 KB 网页链接

$Calidi(CLDI)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001493152-26-004089  Act: 34  Size: 299 KB 网页链接

$Calidi(CLDI)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001493152-25-021418  Act: 34  Size: 10 MB 网页链接

$Calidi(CLDI)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001493152-25-022349  Act: 34  Size: 300 KB 网页链接

$Calidi(CLDI)$ 奥格尼安·安格洛夫·加夫里洛夫已收购Calidi Biotherapeutics, Inc. 7.8%的股份，共计560,000股。这是首次提交Schedule 13G表格，由于无意中的疏忽而延迟提交。加夫里洛夫确认，这些证券的收购并非为了影响发行人的控制权。